BDBM387136 2-((3aS, 7aS)-6-(2-(2H-tetrazol-2- yl)benzoyl)octahydro-1H- pyrrolo[2,3-c]pyridin-1- yl)isonicotinonitrile::US9938276, D2

SMILES O=C(N1CC[C@H]2CCN([C@H]2C1)c1cc(ccn1)C#N)c1ccccc1-n1ncnn1

InChI Key InChIKey=VTNUMMZMVJCUET-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 387136   

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM387136(2-((3aS, 7aS)-6-(2-(2H-tetrazol-2- yl)benzoyl)octa...)
Affinity DataIC50: 110nMAssay Description:The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2020
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM387136(2-((3aS, 7aS)-6-(2-(2H-tetrazol-2- yl)benzoyl)octa...)
Affinity DataIC50: 1.00E+4nMAssay Description:The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2020
Entry Details
US Patent